Nyxoah SA

Cochlear Investments Pty Ltd and its parent Cochlear Limited have filed an amendment to their Schedule 13D, confirming their beneficial ownership of 5,847,283 ordinary shares in Nyxoah SA, representing 5.91% of the outstanding shares.

Cochlear Investments Pty Ltd, a subsidiary of Cochlear Ltd, increased its beneficial ownership in Nyxoah SA to 13.59% of outstanding Ordinary Shares through a recent public offering.

CVI Investments, Inc. and Heights Capital Management, Inc. have disclosed a combined beneficial ownership of 9.9% in Nyxoah SA's ordinary shares, primarily through convertible notes.

ResMed Inc. has filed a Schedule 13G, reporting beneficial ownership of 1,943,828 ordinary shares in Nyxoah SA, representing 1.95% of the outstanding shares.

CVI Investments, managed by Heights Capital Management, disclosed a 9.9% beneficial ownership stake in Nyxoah SA, primarily through convertible notes.

Vestal Point Capital, LP and Ryan Wilder have reported a 3.7% beneficial ownership stake in Nyxoah SA, holding 1,402,002 ordinary shares.

Vestal Point Capital, LP and its Chief Investment Officer, Ryan Wilder, have disclosed a passive 6.2% beneficial ownership stake in Nyxoah SA, holding 2,318,954 ordinary shares.

Vestal Point Capital, LP and Ryan Wilder have jointly disclosed a 7.8% beneficial ownership stake in Nyxoah SA, holding 2,924,216 ordinary shares as of December 31, 2024.